Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Chen, Grace Y.

University Of Michigan At Ann Arbor
United States

Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention 1R21CA273646-01A1 Winfred Malone, Ph.D., M.P.H.
Cheng, Leo L

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 5R01CA273010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Cheville, Andrea Lynne

Mayo Clinic Rochester
United States

Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial 4R33CA278594-02 Brennan Streck, Ph.D., R.N., M.P.H.
Chibwesha, Carla J

Univ Of North Carolina Chapel Hill
United States

Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV 5R01CA250850-04
Chinnaiyan, Arul M

University Of Michigan At Ann Arbor
United States

Michigan-VUMC Biomarker Characterization Center 5U2CCA271854-02
Chirenje, Zvavahera Mike

University Of California, San Francisco
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) 1UG1CA284918-01 Silvina Frech, Ph.D., M.S.
Chow, H-H. Sherry

University Of Arizona
United States

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) 5UG1CA242596-05 RFA-CA-18-029 (UG1 Clinical Trial Required) Donald Johnsey
Chung, Fung-Lung

Georgetown University
United States

gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention 5U01CA220477-05 Wendy Wang, Ph.D., M.Sc.
Chung, Ki Young

Prisma Health - Upstate
United States

NCORP of the Carolinas (Greenville Health System NCORP) 6UG1CA189972-10
Chung, Michael Hoonbae

Emory University
United States

HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) 5UG1CA275400-02 Silvina Frech, Ph.D., M.S.